Literature DB >> 3584120

Smooth muscle caldesmon is an extended flexible monomeric protein in solution that can readily undergo reversible intra- and intermolecular sulfhydryl cross-linking. A mechanism for caldesmon's F-actin bundling activity.

W P Lynch, V M Riseman, A Bretscher.   

Abstract

Caldesmon is a major F-actin binding protein of smooth muscle that has been implicated as a component of a thin filament regulatory system. Chicken gizzard caldesmon consists of polypeptides of Mr-135,000 and 140,000 which are closely related as determined by analysis of cyanogen bromide cleavage fragments. It is a highly extended flexible protein having a contour length of about 146 nm and a secondary structure composed primarily of random coil. Physical and chemical cross-linking data suggest that caldesmon exists as a monomer in solution. The cysteine content of caldesmon was determined to be 2 residues/polypeptide. Remarkably, in solution it readily undergoes sulfhydryl oxidation to form either an internal disulfide bridge in the protein or cross-links between individual polypeptides to form dimers, trimers, tetramers, etc. The internally cross-linked species have a smaller Stokes radius than the reduced molecules, indicating that the cross-link "trapped" the molecule in a compact conformation. Oxidized protein containing caldesmon oligomers is a potent F-actin bundling protein. Complete reduction of caldesmon abolishes the F-actin bundling activity. Since a vast excess of reducing agent is required to convert caldesmon from an oxidized to reduced state, it may exist in either state in vivo. Thus, the ability of caldesmon to undergo reversible sulfhydryl cross-linking, and thereby reversible F-actin cross-linking, may be of physiological significance.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3584120

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  32 in total

1.  Sarcomeric binding pattern of exogenously added intact caldesmon and its C-terminal 20-kDa fragment in skinned fibers of skeletal muscle.

Authors:  S M Frisbie; M C Reedy; L C Yu; B Brenner; J M Chalovich; T Kraft
Journal:  J Muscle Res Cell Motil       Date:  1999-04       Impact factor: 2.698

Review 2.  Natively unfolded proteins: a point where biology waits for physics.

Authors:  Vladimir N Uversky
Journal:  Protein Sci       Date:  2002-04       Impact factor: 6.725

3.  Parallel inhibition of active force and relaxed fiber stiffness in skeletal muscle by caldesmon: implications for the pathway to force generation.

Authors:  B Brenner; L C Yu; J M Chalovich
Journal:  Proc Natl Acad Sci U S A       Date:  1991-07-01       Impact factor: 11.205

Review 4.  The molecular anatomy of caldesmon.

Authors:  S B Marston; C S Redwood
Journal:  Biochem J       Date:  1991-10-01       Impact factor: 3.857

5.  Detection by chemical cross-linking of bovine brain synapsin I self-association.

Authors:  B Font; E Aubert-Foucher
Journal:  Biochem J       Date:  1989-12-15       Impact factor: 3.857

6.  Mode of caldesmon binding to smooth muscle thin filament: possible projection of the amino-terminal of caldesmon from native thin filament.

Authors:  E Katayama; M Ikebe
Journal:  Biophys J       Date:  1995-06       Impact factor: 4.033

7.  Caldesmon and the structure of smooth muscle thin filaments: electron microscopy of isolated thin filaments.

Authors:  C Moody; W Lehman; R Craig
Journal:  J Muscle Res Cell Motil       Date:  1990-04       Impact factor: 2.698

Review 8.  Caldesmon, acidic amino acids and molecular weight determinations.

Authors:  J Bryan
Journal:  J Muscle Res Cell Motil       Date:  1989-04       Impact factor: 2.698

9.  Reversal of caldesmon binding to myosin with calcium-calmodulin or by phosphorylating caldesmon.

Authors:  M E Hemric; F W Lu; R Shrager; J Carey; J M Chalovich
Journal:  J Biol Chem       Date:  1993-07-15       Impact factor: 5.157

10.  Regulation by Ca(2+)-calmodulin of the actin-bundling activity of Physarum 210-kDa protein.

Authors:  R Ishikawa; T Okagaki; K Kohama
Journal:  J Muscle Res Cell Motil       Date:  1992-06       Impact factor: 2.698

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.